Midlife Dietary Intake of Antioxidants and Risk of Late-Life Incident Dementia: The Honolulu-Asia Aging Study
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Antioxidants have been hypothesized to protect against Alzheimer's disease, but studies conducted in late life have been inconsistent. Risk factors measured in midlife may better predict dementia in late life because they are less affected by the disease process. The authors examined the association of midlife dietary intake of antioxidants to late-life dementia and its subtypes. Data were obtained from the Honolulu-Asia Aging Study, a prospective community-based study of Japanese-American men who were aged 45-68 years in 1965-1968, when a 24-hour dietary recall was administered. The analysis included 2,459 men with complete dietary data who were dementia-free at the first assessment in 1991-1993 and were examined up to two times for dementia between 1991 and 1999. The sample included 235 incident cases of dementia (102 cases of Alzheimer's disease, 38 cases of Alzheimer's disease with contributing cerebrovascular disease, and 44 cases of vascular dementia). Relative risks by quartile of intake were calculated using Cox proportional hazards models with age as the time scale, after adjustment for sociodemographic and lifestyle factors, cardiovascular risk factors, other dietary constituents, and apolipoprotein E e4. Intakes of beta-carotene, flavonoids, and vitamins E and C were not associated with the risk of dementia or its subtypes. This analysis suggests that midlife dietary intake of antioxidants does not modify the risk of late-life dementia or its most prevalent subtypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The remaining selected cohort studies (n = 6) did not find a significant association [177,185,187,188,192,199].”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [188]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
Hertog, M. G. L., Feskens, E. J. M., Kromhout, D., Hertog, M. G. L., Hollman, P. C. H., Hertog, M. G. L., & Katan, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92876-u · Cited by 4,341
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
RE: “TOTAL ENERGY INTAKE: IMPLICATIONS FOR EPIDEMIOLOGIC ANALYSES”
Palmgren, J., & Kushi, L. H. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115841 · Cited by 2,711
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 2×
“Compared with placebo, treatment with vitamin E for 2 years in 341 persons with probable Alzheimer’s disease of moderate severity was beneficial in slowing the progression of disease, but no improvement in cognitive test scores was noticed (17).”
BackgroundMethod15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“Oxidative stress has also been implicated in cardiovascular diseases, which in turn have been associated with the occurrence of Alzheimer’s disease and vascular dementia (3, 4).”
BackgroundAntioxidants and Atherosclerotic Heart Disease
Diaz, M. N., Frei, B., Vita, J. A., & Keaney, J. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370607 · Cited by 1,353
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080
Cited by
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,181
Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921
“Broe, 1998 (12)y 5.81 1.03 0.45, 2.37 Laurin, 2004 ( 15 )z 23.03 1.03 0.68, 1.56”
BackgroundResultInfluentialA Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
“An epidemiological study of Dutch adults, for example, found that total dietary flavonoid intake was not associated with the risk of developing AD [212, 213].”
BackgroundBeydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
“Similarly, Laurin and colleagues [188] found no association between midlife dietary intake of vitamins E and C and dementia incidence.”
BackgroundNutrition and prevention of cognitive impairment
Scarmeas, N., Anastasiou, C. A., & Yannakoulia, M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30338-7 · Cited by 612
Involvement of oxidative stress in Alzheimer disease
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611
Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
Praticò, D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.001 · Cited by 606
Fruit and Vegetable Juices and Alzheimer’s Disease: The Kame Project
Dai, Q., Borenstein, A. R., Wu, Y., Jackson, J. C., & Larson, E. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.045 · Cited by 529
Singh, M., Arseneault, M., Sanderson, T., Murthy, V., & Ramassamy, C. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0735073 · Cited by 439
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428
“In this study and in the previous longitudinal studies [2,5,6], no association was found between tea drinking and the risk of dementia/AD.”
Román, G. C., Jackson, R. E., Gadhia, R., Román, A. N., & Reis, J. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.08.005 · Cited by 421
Food Combination and Alzheimer Disease Risk: A Protective Diet
Gu, Y. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.84 · Cited by 414
Hypertension: A Harbinger of Stroke and Dementia
Faraco, G., & Iadecola, C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01063 · Cited by 367
Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118333 · Cited by 362
Current Pharmacotherapy for Alzheimer's Disease
Lleó, A., Greenberg, S. M., & Growdon, J. H. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131442 · Cited by 345
Cataldo, J. K., Prochaska, J. J., & Glantz, S. A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1240 · Cited by 335
Inflammaging as a prodrome to Alzheimer's disease
Giunta, B., Fernandez, F., Nikolic, W. V., Obregon, D., Rrapo, E., Town, T., & Tan, J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-51 · Cited by 327
“was not associated with the risk of developing AD [226,227], except in current smokers whose risk of AD decreased by half for every 12 mg increase in daily flavo-”
Cardiovascular disease and Alzheimer's disease: common links
STAMPFER, M. J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01687.x · Cited by 324
Praticò, D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.010 · Cited by 313
Fruit and vegetable consumption and cognitive decline in aging women
Kang, J. H., Ascherio, A., & Grodstein, F. (2005) · Annals of Neurology · doi:10.1002/ana.20476 · Cited by 303
Dietary Antioxidants and Long-term Risk of Dementia
Devore, E. E., Grodstein, F., van Rooij, F. J. A., Hofman, A., Stampfer, M. J., Witteman, J. C. M., & Breteler, M. M. B. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.144 · Cited by 276
“Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo.”
BackgroundAntioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
Mecocci, P., & Polidori, M. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.006 · Cited by 270
“Prospective cohort studies on flavonoids intake and risk of developing dementia led to inconsistent results [27, 40–44].”
ResultCaffeine as a Protective Factor in Dementia and Alzheimer's Disease
Eskelinen, M. H., & Kivipelto, M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1404 · Cited by 259
“, 2004 [17] HAAS, Hawaii, USA N = 2459, 45–68 years, (mean: 52.”
MethodInfluentialTelomere length predicts poststroke mortality, dementia, and cognitive decline
Martin-Ruiz, C., Dickinson, H. O., Keys, B., Rowan, E., Kenny, R. A., & Von Zglinicki, T. (2006) · Annals of Neurology · doi:10.1002/ana.20869 · Cited by 261
“6) Median MMSE score at baseline (interquartile range) 27 (25-28) 27 (25-28) 27 (24-28) 27 (25-28) 27 (25-29) Men, n (%) 107 (55) 25 (52) 28 (57) 29 (59) 25 (51) Number of participants with: Atrial fibrillation, n (%) 27 (14) 5 (10) 6 (12) 8 (16) 8 (16) Hypertension, n (%) 111 (57) 25 (52) 29 (59) 29 (59) 28 (57) Card…”
Systematic review of health behavioral risks and cognitive health in older adults
Lee, Y., Back, J. H., Kim, J., Kim, S.-H., Na, D. L., Cheong, H.-K., Hong, C. H., & Kim, Y. G. (2010) · International Psychogeriatrics · doi:10.1017/s1041610209991189 · Cited by 249
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 248
“, 2004) (other studies did not confirm these findings (Laurin et al., 2004)).”
Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
Ferrer, M. D., Busquets-Cortés, C., Capó, X., Tejada, S., Tur, J. A., Pons, A., & Sureda, A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180514112124 · Cited by 246
Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges
Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., & Hensley, K. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15314 · Cited by 237
“The Honolulu-Asia Aging study (2459 men; vitamin E alone) [80,92,118] investigated dietary intake of antioxidants in middle aged versus old-aged subjects for protection against dementia.”
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Tayeb, H. O., Yang, H. D., Price, B. H., & Tarazi, F. I. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.002 · Cited by 230
Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies
Cao, L., Tan, L., Wang, H.-F., Jiang, T., Zhu, X.-C., Lu, H., Tan, M.-S., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9516-4 · Cited by 230
“Among these articles, 19 were from the USA [14–31], 7 were from Netherlands [32–38], 5 were from France [39–43], 3 were from Sweden [44–46], 3 were from Italy [47–49], 2 were from Australia [50, 51], 2 were from UK [52, 53], 1 was from Canada [54], and 1 was from Denmark [55].”
BackgroundLoef, M., & Walach, H. (2012) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0097-x · Cited by 225
Melatonin in Alzheimer's disease and other neurodegenerative disorders
Srinivasan, V, Pandi-Perumal, Sr., Cardinali, D., Poeggeler, B., & Hardeland, R. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-15 · Cited by 223
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
Rezai-Zadeh, K., Ehrhart, J., Bai, Y., Sanberg, P. R., Bickford, P., Tan, J., & Shytle, R. D. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-41 · Cited by 216
“Recent research has focused on the analysis of flavonoids, which epidemiological study suggest are beneficial against the neurodegeneration and aging processes [29-33].”
BackgroundDi Marco, L. Y., Marzo, A., Muñoz-Ruiz, M., Ikram, M. A., Kivipelto, M., Ruefenacht, D., Venneri, A., Soininen, H., Wanke, I., Ventikos, Y. A., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132225 · Cited by 215
Diet, cognition, and alzheimer’s disease: food for thought
Otaegui-Arrazola, A., Amiano, P., Elbusto, A., Urdaneta, E., & Martínez-Lage, P. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0561-3 · Cited by 214
Cognitive decline, dietary factors and gut–brain interactions
Caracciolo, B., Xu, W., Collins, S., & Fratiglioni, L. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.011 · Cited by 204
A Review of Antioxidants and Alzheimer's Disease
Frank, B., & Gupta, S. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230500296428 · Cited by 198
Effects of Concord grape juice on cognitive and motor deficits in aging
Shukitt-Hale, B., Carey, A., Simon, L., Mark, D. A., & Joseph, J. A. (2006) · Nutrition · doi:10.1016/j.nut.2005.07.016 · Cited by 198
Panza, F., Solfrizzi, V., Barulli, M. R., Bonfiglio, C., Guerra, V., Osella, A., Seripa, D., Sabbà, C., Pilotto, A., & Logroscino, G. (2015) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0563-8 · Cited by 194
“…effect of coffee, tea, and caffeine The Canadian Study of Health and Aging consumption or plasma caffeine levels against Laurin et al., 2004 (66) dementia and AD The Honolulu-Asia Aging Study Dai et al., 2006 (67) The Kame Project Eskelinen et al., 2009 (68) The Cardiovascular Risk Factors,…”
InfluentialCardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189
Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau
KITAZAWA, M., YAMASAKI, T. R., & LAFERLA, F. M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.006 · Cited by 176
Noguchi-Shinohara, M., Yuki, S., Dohmoto, C., Ikeda, Y., Samuraki, M., Iwasa, K., Yokogawa, M., Asai, K., Komai, K., Nakamura, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096013 · Cited by 174
“In addition, longitudinal studies of black tea consumption have not found any association with reduced risks for dementia, AD, or cognitive decline [14,15].”
BackgroundResultLi, F.-J., Shen, L., & Ji, H.-F. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120349 · Cited by 173
“show that dietary intakes of antioxidants, such as vitamin E, vitamin C, and -carotene, can ward off AD [13–17], while the beneficial effects of antioxidant supplements are not observed in other studies [18, 19].”
BackgroundVitamin C Status and Cognitive Function: A Systematic Review
Travica, N., Ried, K., Sali, A., Scholey, A., Hudson, I., & Pipingas, A. (2017) · Nutrients · doi:10.3390/nu9090960 · Cited by 170
“Laurin, 2003 [58] Pros 2549 Men 45–68 4 Hasegawa dementia screening instrument, MMSE, 3MS 24-h dietary recall Vit C was not associated with the risk of dementia or its subtypes across an 8-year period”
BackgroundLafortune, L., Martin, S., Kelly, S., Kuhn, I., Remes, O., Cowan, A., & Brayne, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0144405 · Cited by 165
“One reported a non-significant relationship between mid-life dietary antioxidant intake, flavonoids and dementia [78].”
BackgroundCorrada, M. M., Kawas, C. H., Hallfrisch, J., Muller, D., & Brookmeyer, R. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.001 · Cited by 159
“Regarding dietary intake, studies have found a protective effect with intake of vitamin E [4,5] or vitamin C [4], whereas others have not found an effect [23,24].”
BackgroundDementia Prevention: Methodological Explanations for Inconsistent Results
Coley, N., Andrieu, S., Gardette, V., Gillette-Guyonnet, S., Sanz, C., Vellas, B., & Grand, A. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn010 · Cited by 154
“Five studies found no association between vitamin E (37, 44, 45), vitamin C (22, 37, 44–46), flavonoids (44), or beta-carotene (22, 31, 44–46) and dementia/Alzheimer disease or cognitive decline.”
BackgroundDietary Antioxidants, Cognitive Function and Dementia - A Systematic Review
Crichton, G. E., Bryan, J., & Murphy, K. J. (2013) · Plant Foods for Human Nutrition · doi:10.1007/s11130-013-0370-0 · Cited by 175
“Other dietary assessment methods used included 24-hour dietary recalls [35, 38] and 3- or 7-day food records [39, 41–43, 45].”
BackgroundMethodResultInfluentialModifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Hughes, T., & Ganguli, M. (2009) · Current Psychiatry Reviews · doi:10.2174/157340009788167347 · Cited by 152
Vascular Dementia Prevention: A Risk Factor Analysis
Román, G. C. (2005) · Cerebrovascular Diseases · doi:10.1159/000089361 · Cited by 150
“with higher energy intake from fats, in particular polyunsaturated fatty acids and decrease in antioxidant vitamins B, C, and carotene. However, in the Honolulu-Asia Aging Study [”
BackgroundShishtar, E., Rogers, G. T., Blumberg, J. B., Au, R., & Jacques, P. F. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa079 · Cited by 149
Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers
Trippier, P. C., Labby, K. J., Hawker, D. D., Mataka, J., & Silverman, R. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3015926 · Cited by 156
Alzheimer's disease and diet: a systematic review
Yusufov, M., Weyandt, L. L., & Piryatinsky, I. (2017) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1155572 · Cited by 140
Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 156
Neuronal death in Alzheimer’s disease and therapeutic opportunities
Donev, R., Kolev, M., Millet, B., & Thome, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00889.x · Cited by 126
“Other clinical trials also failed to show beneficial effects of vitamin E administration to AD patients [173–175].”
BackgroundThe Role of Nutrition and Diet in Alzheimer Disease: A Systematic Review
Shah, R. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.01.014 · Cited by 145
Midlife Fruit and Vegetable Consumption and Risk of Dementia in Later Life in Swedish Twins
Hughes, T. F., Andel, R., Small, B. J., Borenstein, A. R., Mortimer, J. A., Wolk, A., Johansson, B., Fratiglioni, L., Pedersen, N. L., & Gatz, M. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181c65250 · Cited by 121
“This finding is consistent with findings from the Honolulu, Hawaii-Asia Aging Study where midlife antioxidant intake did not predict incident dementia more than 30 years of follow-up in an all male sample.(26) Some have shown that women are at greater risk dementia and AD.”
Long-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and Women
Yeh, T., Yuan, C., Ascherio, A., ROSNER, B. A., Willett, W. C., & Blacker, D. (2021) · Neurology · doi:10.1212/wnl.0000000000012454 · Cited by 143
Zaccai, J., Ince, P., & Brayne, C. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-2 · Cited by 112
“One of the major objectives of HAAS was to compare rates of dementia in a cohort of JapaneseAmerican men in Hawaii with rates of Japanese living in Japan and the United States mainland [45-63].”
BackgroundNeurobiology of vitamin C: Expanding the focus from antioxidant to endogenous neuromodulator
Ballaz, S. J., & Rebec, G. V. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104321 · Cited by 105
Neuronal and Vascular Oxidative Stress in Alzheimers Disease
A. Massaad, C. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376244 · Cited by 103
“However, the counterpart of such studies in humans yielded conflicting results: While observational epidemiological studies are consistent with the hypothesis that there is an inverse relationship between antioxidant intake and AD risk [125-128], randomized clinical trials do not unanimously support this hypothesis [1…”
ResultStrategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants
Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.955853 · Cited by 102
“Vitamin E alone or in combination with other vitamins and minerals showed no association with dementia [127–129], while others noted a correlation with improved cognitive performance [130–134].”
BackgroundNature and Nurture: Genetic and Environmental Influences on Behavior
Plomin, R., & Asbury, K. (2005) · The ANNALS of the American Academy of Political and Social Science · doi:10.1177/0002716205277184 · Cited by 100
“…allele 4 and LOAD was reported only a decade ago (Corder et al. 1993), much research on dementia now genotypes participants for APOE to ascertain whether results differ for individuals with and without this genetic risk factor (e.g., Laurin et al. 2004; Mukamal et al. 2003; Podewils et al. 2005).”
BackgroundTargets for the Prevention of Dementia
Middleton, L. E., & Yaffe, K. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091657 · Cited by 94
“However, other large, prospective, observational studies found no association between vitamin intake and dementia risk [111, 112].”
Bookheimer, S. Y., Renner, B. A., Ekstrom, A., Li, Z., Henning, S. M., Brown, J. A., Jones, M., Moody, T., & Small, G. W. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/946298 · Cited by 93
“Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2013, Article ID 946298, 14 pages http://dx.doi.org/10.1155/2013/946298”
BackgroundInfluentialCarotenoid-rich dietary patterns during midlife and subsequent cognitive function
Kesse-Guyot, E., Andreeva, V. A., Ducros, V., Jeandel, C., Julia, C., Hercberg, S., & Galan, P. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003188 · Cited by 92
“However, two cross-sectional studies on cognitive function (22,23) and five longitudinal studies on cognitive decline (24,25) and risk of dementia (26–28) have not reported such associations.”
Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy
Cente, M., Filipcik, P., Pevalova, M., & Novak, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04986.x · Cited by 82
“studies have failed to detect any beneficial effects of antioxidant therapies, and have instead concluded that the intake of carotenes, vitamin C and vitamin E was not associated with reduced incidence of AD (Luchsinger et al., 2003; Laurin et al., 2004).”
ResultLott, I. T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.010 · Cited by 82
Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem
Swerdlow, R. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1676 · Cited by 81
“Some epidemiologic surveys suggest increased intake of standard antioxidant vitamins (including vitamin E, vitamin C, and beta carotene) might reduce the risk of developing AD or PD, while others do not (43, 44, 92, 99, 186).”
Jia, Q., Deng, Y., & Qing, H. (2014) · BioMed Research International · doi:10.1155/2014/837157 · Cited by 81
“Flavonoid administration prevented cognitive impairment associated with inflammation in animal studies [147, 148]; however, the beneficial effects cannot be repeated in human [149].”
BackgroundRhein, V., Giese, M., Baysang, G., Meier, F., Rao, S., Schulz, K. L., Hamburger, M., & Eckert, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012359 · Cited by 81
“long-term follow-up periods [7,46] raising the question of the Figure 5.”
BackgroundPattern of polyphenol intake and the long-term risk of dementia in older persons
Lefèvre-Arbogast, S., Gaudout, D., Bensalem, J., Letenneur, L., Dartigues, J.-F., Hejblum, B. P., Féart, C., Delcourt, C., & Samieri, C. (2018) · Neurology · doi:10.1212/wnl.0000000000005607 · Cited by 80
“Likewise, cohorts that examined total flavonoid/polyphenol intakes in midlife in relation to cognition or dementia risk in older ages found inconsistent results.(5,14) Total polyphenol intake was significantly associated with better global cognitive performance at baseline in our cohort (results not shown and availabl…”
Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer’s disease
Polidori, M. C., Griffiths, H. R., Mariani, E., & Mecocci, P. (2007) · Amino Acids · doi:10.1007/s00726-006-0431-x · Cited by 81
“…of antioxidants showed a higher efficacy than supplementation in preventing Alzheimer’s disease, suggesting that the antioxidant mixture contained in food is more effective (Engelhart et al., 2002; Morris et al., 2002) although other studies did not confirm these findings (Laurin et al., 2004).”
ResultHealth-Promoting Strategies for the Aging Brain
Chen, S. T., Volle, D. C., Jalil, J., Wu, P., & Small, G. W. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.12.016 · Cited by 75
The Epidemiological Scale of Alzheimer’s Disease
Cornutiu, G. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2106w · Cited by 70
“Among the protective factors, many authors point out the nutritional factor (diet) [82-87].”
BackgroundAntioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice
Harrison, F. E., Allard, J., Bixler, R., Usoh, C., Li, L., May, J. M., & McDonald, M. P. (2009) · Nutritional Neuroscience · doi:10.1179/147683009x423364 · Cited by 71
Montiel, T., Quiroz‐Baez, R., Massieu, L., & Arias, C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.126 · Cited by 77
Diet and cognitive decline at middle age: the role of antioxidants
Nooyens, A. C. J., Milder, I. E. J., van Gelder, B. M., Bueno-de-Mesquita, H. B., van Boxtel, M. P. J., & Verschuren, W. M. M. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515000720 · Cited by 69
Vitamin E and Risk of Cardiovascular Diseases: A Review of Epidemiologic and Clinical Trial Studies
Gonzalez, Z. C., Drogan, D., Weikert, C., & Boeing, H. (2010) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802304230 · Cited by 75
“…possible to combine antioxidants in a score or index that will be able to analyse the effect of antioxidants on CVD outcomes, as it has been reported on other diseases (e.g., cancer, osteoporosis, Alzheimer) (Van Hoydonck et al., 2002; Laurin et al., 2004; Wright et al., 2004; Zhang et al., 2006).”
BackgroundSolfrizzi, V., and for the Italian Longitudinal Study on Aging Working Group 2, Panza, F., Imbimbo, B. P., D’Introno, A., Galluzzo, L., Gandin, C., Misciagna, G., Guerra, V., Osella, A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150333 · Cited by 65
Diet and Inflammation in Alzheimer’s Disease and Related Chronic Diseases: A Review
Gardener, S. L., Rainey‐Smith, S. R., & Martins, R. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150765 · Cited by 70
Nutrition and vascular dementia
Perez, L., Helm, L., Sherzai, A., Jaceldo‐Siegl, K., & Sherzai, A. Z. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0042-z · Cited by 70
“(23) did not find a statistically significant relationship between beta carotene, vitamin C or flavonoid intake in midlife, and risk of developing late life incident dementia, AD, Alzheimer’s with and without cerebrovascular disease, and VaD.”
InfluentialNatural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis
Yamada, M., Ono, K., Hamaguchi, T., & Noguchi‐Shinohara, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_4 · Cited by 72
von Arnim, C. A. F., the ActiFE Ulm study group, Herbolsheimer, F., Nikolaus, T., Peter, R., Biesalski, H. K., Ludolph, A. C., Riepe, M., & Nagel, G. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120634 · Cited by 62
“No association for vitamin C intake was also found in prospective studies [21, 22], however, inverse associ-”
Radicales libres, antioxidantes naturales y mecanismos de protección
Avello, M., & Suwalsky, M. (2006) · Atenea · doi:10.4067/s0718-04622006000200010 · Cited by 178
Beydoun, M. A., Fanelli-Kuczmarski, M. T., Kitner-Triolo, M. H., Beydoun, H. A., Kaufman, J. S., Mason, M. A., Evans, M. K., & Zonderman, A. B. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000129 · Cited by 61
“Similarly, Laurin and colleagues (23) found no association between midlife dietary intake of vitamins E and C and dementia incidence.”
BackgroundMore than the sum of its parts? Nutrition in Alzheimer's disease
Arnim, C. A. F. V., Gola, U., & Biesalski, H. K. (2010) · Nutrition · doi:10.1016/j.nut.2009.11.009 · Cited by 73
Bansal, R., & Singh, R. (2017) · Medicinal Research Reviews · doi:10.1002/med.21458 · Cited by 65
Beydoun, M. A., Beydoun, H. A., Kuczmarski, M. F., Weiss, J., Hossain, S. A., Canas, J. A., Evans, M. K., & Zonderman, A. B. (2022) · Neurology · doi:10.1212/wnl.0000000000200289 · Cited by 85
George, E., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190232 · Cited by 60
Do dietary patterns influence cognitive function in old age?
Corley, J., Starr, J. M., McNeill, G., & Deary, I. J. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213000793 · Cited by 52
“Some studies have reported no association between risk of dementia in later life and dietary antioxidant intake at midlife in a male sample (Laurin et al., 2004) and with midlife fruit and vegetable intake in males (Hughes et al.”
BackgroundYang, W., Cui, K., Li, X., Zhao, J., Zeng, Z., Song, R., Qi, X., & Xu, W. (2021) · The journal of nutrition health & aging · doi:10.1007/s12603-021-1685-4 · Cited by 62
“As an example, a single 24-hour dietary recall may not represent usual food selection (19).”
Ancelin, M.-L., Christen, Y., & Ritchie, K. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000102567 · Cited by 50
“A recent study found no association between midlife intake and risk of late-onset AD 30 years later, however, dietary intake was only evaluated at baseline [”
BackgroundGodos, J., Micek, A., Mena, P. R., Rio, D. D., Galvano, F., Castellano, S., & Grosso, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300472 · Cited by 62
Montinaro, M., Uberti, D. L., Maccarinelli, G., Bonini, S. A., Ferrari‐Toninelli, G., & Memo, M. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.008 · Cited by 48
“…the results obtained by these studies remain rather controversial, with no clear results of whether they are able to counteract AD progression over a long-term period of diet intake (Engelhart et al., 2002; Morris et al., 2002; Luchsinger et al., 2003; Laurin et al., 2004; Miller et al., 2005).”
ResultSavica, R., & Petersen, R. C. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.11.006 · Cited by 63
Ye, X., Bhupathiraju, S. N., & Tucker, K. L. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001183 · Cited by 50
Lim, S., Mohaimin, S., Min, D., Roberts, T. R., Sohn, Y.-J., Wong, J., Sivanesathurai, R., Kwon, S. C., & Trinh‐Shevrin, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200509 · Cited by 57
“Data was inconclusive around the protective value of intake of vitamin E and C, with some studies suggesting an inverse relationship between intake and incident ADRD [74, 79] and oth-ersshowingnorelationship[73].”
Metadata
- Authors
- Laurin, D.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Laurin, D.
- ORCID
- Laurin, D.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-15
- Volume
- 159
- Issue
- 10
- Pages
- 959-967
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2142806233
- Cited by
- 231
- References
- 40
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 8 · 2020: 6 · 2019: 8 · 2018: 10 · 2017: 6 · 2016: 6 · 2015: 9 · 2014: 16 · 2013: 17 · 2012: 10
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc005102-027)
- U.S. Public Health Service (G3-0336)
- National Institute on Aging (N01‐AG‐4‐2149)
- National Heart, Lung, and Blood Institute (N01 HC 05102)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dietary antioxidants, dementia, Alzheimer's disease, vascular dementia, beta-carotene, flavonoids, vitamin E, vitamin C, apolipoprotein E e4, Japanese-American men, Honolulu-Asia Aging Study
- MeSH terms
- Aged, Aging, Alzheimer Disease, Antioxidants, Ascorbic Acid, Asian, Dementia, Diet Surveys, Feeding Behavior, Flavonoids, Hawaii, Humans, Longitudinal Studies, Male, Middle Aged, Smoking, Vitamin E, Dementia, Vascular, Incidence, Age Distribution, Risk Assessment, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.